Table 2.
Univariate analyses: prognostic factors for 5 year overall survival, disease-free survival, disease-specific survival, and local control.
| Prognostic factor | Overall survival | Disease-free survival | Disease-specific survival | Local control | ||||
|---|---|---|---|---|---|---|---|---|
| 5 year (%) | p | 5 year (%) | p | 5 year (%) | p | 5 year (%) | p | |
| Stage | 0.001 | 0.003 | 0.033 | 0.001 | ||||
| Stage 0 | 86 | 72.1 | 95.8 | 79.2 | ||||
| Stage 1 | 84 | 74.9 | 95.5 | 93.1 | ||||
| Stage 2 | 67.6 | 62.4 | 88.6 | 78.7 | ||||
|
| ||||||||
| Anterior commissure infiltration | <0.001 | <0.001 | <0.001 | <0.001 | ||||
| No | 87.3 | 79.3 | 96.7 | 92.7 | ||||
| Yes | 79 | 66.6 | 93.6 | 85.6 | ||||
|
| ||||||||
| Radiotherapy techniques | 0.61 | 0.51 | 0.231 | 0.769 | ||||
| Conventional | 81 | 73.1 | 95.6 | 86.5 | ||||
| 3DCRT | 83 | 71.8 | 92.2 | 90.9 | ||||
| VMAT | 87.2 | 76.7 | 100 | 94.7 | ||||
|
| ||||||||
| Beam energy | 0.52 | 0.55 | 0.028 | 0.266 | ||||
| Cobalt-60 | 79.2 | 72.2 | 91.2 | 86.6 | ||||
| 6 MV X-rays | 85.4 | 72.5 | 98.4 | 91.4 | ||||
| Log-rank test (95% CI) | ||||||||